Why are biologic drugs expensive? Will Trump’s plans make them cheaper?
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.